Avibactam Sodium From China: A Buyer’s Sourcing Guide

Understanding Avibactam Sodium in the Anti-Infective Supply Chain

Avibactam Sodium (CAS 1192491-61-4) belongs to the class of beta-lactamase inhibitors and sits within the anti-infective product category that also includes cephalosporin intermediates and antiviral agents. For pharmaceutical companies and API manufacturers developing or producing anti-infective formulations, sourcing Avibactam Sodium requires more than a single transaction — it requires a supplier capable of supporting the full synthesis pathway, from early-stage building blocks to the final active ingredient, along with the documentation needed for downstream regulatory work.

In the current anti-infective supply landscape, this product line is positioned as intermediates and API building blocks for antibacterial and antiviral drugs, with target customers including API manufacturers and CDMO institutions serving anti-infective drug markets. This positioning reflects a practical reality: buyers rarely need Avibactam Sodium in isolation. They need the surrounding chemistry — core nucleus intermediates, protected amines, and cyclized precursors — delivered with consistent quality across every batch.

What International Buyers Should Evaluate When Sourcing From China

Full-Chain Intermediate Availability

A recurring pain point for buyers of specialty intermediates is fragmented sourcing: having to coordinate multiple suppliers to assemble a complete synthesis route, which raises procurement costs and introduces quality variability between batches. For Avibactam Sodium specifically, a buyer benefits from access to the related chain of intermediates, including O-Benzylhydroxylamine Hydrochloride (CAS 2687436), (2S,5R)-Phenoxyamide piperidine-2-carboxylic acid ethyl ester oxalate (CAS 1416134489), (2S,5R)-5-[(Benzyloxy)amino]piperidine-2-carboxamide dihydrochloride (CAS 1416134490), (2S,5R)-6-Benzyloxy-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide (CAS 1192651492), and the Avibactam Core Nucleus (CAS 1416134536). Securing these from a single source reduces coordination overhead and supports more consistent process validation.

Quality Documentation and Regulatory Support

Buyers preparing drug master files or seeking certificates for international filings need complete technical documentation. This includes Certificates of Analysis (COA), method of analysis (MOA) methodology, impurity profile studies, and stability data — the documentation set that supports DMF and CEP global regulatory filings. Without this paperwork, even a chemically sound product can stall in a buyer’s own regulatory process.

Production Scale and Capacity

Industry pain points commonly cited include extended supply lead times and inconsistent batch quality that causes production interruptions. Buyers should assess whether a supplier operates production infrastructure sufficient to avoid these interruptions — for example, coordinated production bases equipped with a substantial number of reactor vessels and annual production capacity measured in the hundreds of tons, which together support both small-batch R&D orders and larger commercial volumes.

Delivery and After-Sales Service

Lead time matters as much as price. In-stock orders that can be delivered within 7–15 working days (covering order confirmation, quality review, packaging, and shipping) give buyers predictability, while made-to-order timelines tied to synthesis complexity, workshop scheduling, and raw material availability should be communicated transparently. After-sales responsiveness — such as routine technical issues addressed within 2 hours and complex technical issues resolved with a written report within 24 hours — is a practical indicator of supplier reliability once an order has shipped.

Tianming Pharmaceutical’s Anti-Infective Product Line

Shandong Tianming Pharmaceutical Group, operating under the brand Tianming Pharmaceutical, is a research-and-development-driven pharmaceutical raw material and intermediate enterprise built on an integrated R&D-production model. The group traces its origins to Shandong Sihuan Pharmaceutical Co., Ltd., founded in 2010, with the group structure formally established in 2020. Headquartered in Jinan, Shandong Province, the company’s business coverage extends across domestic China’s East China, North China, and South China pharmaceutical industry clusters, as well as international markets spanning more than 30 countries and regions across South Asia, Southeast Asia, the Middle East, Central and South America, and Africa.

Within this structure, Avibactam Sodium is offered as part of the Anti-Infective Products category, alongside its related intermediates listed above. This product line reflects the company’s broader strategic positioning: providing API, intermediates, and CMO/CDMO custom development and production solutions to the global pharmaceutical industry.

Why Buyers Evaluate Tianming Pharmaceutical for Avibactam Sodium Sourcing

Several operational characteristics are directly relevant to buyers weighing where to source Avibactam Sodium and its intermediates.

Production is coordinated across three production bases — Shandong Sihuan Pharmaceutical Co., Ltd. in Dezhou, Jining Tianming Pharmaceutical Co., Ltd. in Jining, and Guangxi Tianming Pharmaceutical Co., Ltd. in Hechi, Guangxi — operating with over 160 reactor vessels and annual production capacity in the hundreds of tons. This scale is paired with two R&D centers, in Jinan and Nanjing, with laboratory space exceeding 6,000 square meters and an R&D team of more than 100 personnel. Annual R&D investment above 10% of revenue supports ongoing process development work.

On the quality and compliance side, the company operates under a GMP-compliant quality assurance system and ISO9001 certification, including ISO9001 certification held by Shandong Sihuan Pharmaceutical Co., Ltd. (2025) and Guangxi Tianming Pharmaceutical Co., Ltd. (2024). National High-Tech Enterprise recognitions have been granted to Shandong Sihuan Pharmaceutical Co., Ltd. (2024), Shandong Tianming Pharmaceutical Technology Co., Ltd. (2025), and Guangxi Tianming Pharmaceutical Co., Ltd. (2023). Full batch traceability covers raw material receipt, reaction parameters, purification processes, and testing data, with complete COA and structural confirmation documentation available for products.

Operationally, the company manages orders through a CRM, ERP, and BPM digital management system supporting order management, inventory, production scheduling, and customer service coordination, which supports faster domestic order confirmation and coordinated international logistics. International delivery options include air freight, sea freight, and express courier, with cold chain handling available for temperature-sensitive materials and nitrogen-filled vacuum packaging for oxidation-sensitive products, along with transport insurance on orders.

Service support follows a 1-on-1 account manager plus technical engineer model, with routine technical questions addressed with reference solutions within 2 hours and complex technical issues resolved with a written report within 24 hours. Supply flexibility spans gram-level to ton-level quantities, allowing buyers to move from laboratory evaluation through pilot-scale validation to commercial procurement with the same supplier relationship. The company currently works with more than 2,000 cooperative customers across its product range.

A Practical Checklist for Buyers

Before finalizing a purchase order for Avibactam Sodium or related intermediates, buyers should confirm: availability of the full intermediate chain rather than a single isolated compound; a complete documentation package (COA, MOA, impurity studies, stability data) suitable for DMF or CEP filing support; production capacity and reactor availability sufficient for the required order volume; clear delivery timelines distinguishing in-stock versus made-to-order lead times; and a defined after-sales support structure for technical questions that arise post-delivery.

Conclusion

Sourcing Avibactam Sodium from China involves evaluating far more than unit price. Buyers benefit from suppliers that combine full-chain intermediate access, GMP-compliant quality systems, adequate production scale, and responsive technical support. Shandong Tianming Pharmaceutical Group’s Anti-Infective Products line, backed by coordinated production bases, dedicated R&D centers, and documented quality control processes, reflects the operational characteristics that buyers in this category typically assess when making sourcing decisions.

Home

Tianming Pharmaceutical Group